# US 2008/0187999 A1 · Methods and systems for high homologous recombination ("HR") targeting efficiency

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2008/0187999 A1
- Document ID: US20080187999A1
- Status: Published application
- Kind: A1
- Application number: 11/702,865
- Filed: 2007-02-06
- Published: 2008-08-07
- Earliest claimed: 2007-02-06
- Assignees: Geneprotech, Inc.
- Inventors: Uthayashanker Ezekiel
- Web page: https://patentgrep.com/patent/US20080187999A1

## CPC

- A61K 48/005: {characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered}
- C12N 15/85: for animal cells
- C12N 2800/00: Nucleic acids vectors
- C12N 2810/40: Vectors comprising a peptide as targeting moiety, e.g. a synthetic peptide, from undefined source
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

Disclosed are vectors, kits and methods useful in the construction of recombinant cells and DNAs via enhanced efficiency homologous recombination. The vectors are targeting vectors that contain a gene-of-interest spliced between two ends that are homologous to a genome target site. The ends of the vector may be protected from exonuclease attack by deploying a cap, such as a hair pin structure. The vector is linked to a nuclear localization signal sequence, and preferably, a bait peptide that binds to RAD51, to facilitate homologous recombination. The vector may be deployed in myriad genetic transformation applications, such as site-directed mutagenesis, gene therapy, and the like.

## Claims

### Claim 1

A targeting vector for homologous recombination, comprising (a) a polynucleotide that encodes a gene-product-of-interest, (b) a proximal polynucleotide having a sequence that is homologous to a proximal part of a target polynucleotide, (c) a distal polynucleotide having a sequence that is homologous to a distal part of a target polynucleotide, (d) and a nuclear localization signal (“NLS”) attached to the end of either the proximal polynucleotide or the distal polynucleotide.

### Claim 2 (depends on 1)

The targeting vector of claim 1 wherein the gene-product of interest is a cellular marker.

### Claim 3 (depends on 2)

The targeting vector of claim 2 wherein the cellular marker is selected from the group consisting of beta lactamase, neomycin resistance, green fluorescent protein, and luciferase.

### Claim 4 (depends on 1)

The targeting vector of claim 1 wherein the gene-product of interest is a protein.

### Claim 5 (depends on 4)

The targeting vector of claim 4 wherein the protein is selected from the group consisting of IL-2 receptor y chain, deaminase, and nicotinamide adenine dinucleotide phosphate oxidase.

### Claim 6 (depends on 1)

The targeting vector of claim 1 wherein the target polynucleotide is hypoxanthine-guanine phosphoribosyltransferase (“HPRT”).

### Claim 7 (depends on 1)

The targeting vector of claim 1 wherein the target polynucleotide is selected from the group consisting of a polynucleotide that encodes any one of IL-2 receptor γ chain, deaminase, and nicotinamide adenine dinucleotide phosphate oxidase.

### Claim 8 (depends on 1)

The targeting vector of claim 1 wherein the target vector further comprises a bait polypeptide attached to the end of either the proximal polynucleotide, wherein the NLS sequence is attached to the distal polynucleotide, or the distal polynucleotide, wherein the NLS sequence is attached to the proximal polynucleotide.

### Claim 9 (depends on 8)

The targeting vector of claim 8 wherein the bait polypeptide binds to RAD51.

### Claim 10 (depends on 9)

The targeting vector of claim 9 wherein the bait polypeptide comprises a sequence having at least 70% identity to any one of SEQ ID NO: 1, SEQ ID NO: 2 and SEQ ID NO: 3.

### Claim 11 (depends on 9)

The targeting vector of claim 9 wherein the bait polypeptide consists of a sequence having at least 70% identity to any one of SEQ ID NO: 1, SEQ ID NO: 2 and SEQ ID NO: 3.

### Claim 12 (depends on 9)

The targeting vector of claim 9 wherein the bait polypeptide comprises a sequence set forth in any one of SEQ ID NO: 1, SEQ ID NO: 2 and SEQ ID NO: 3.

### Claim 13 (depends on 9)

The targeting vector of claim 9 wherein the bait polypeptide consists of a sequence set forth in any one of SEQ ID NO: 1, SEQ ID NO: 2 and SEQ ID NO: 3.

### Claim 14 (depends on 9, 10, 11, 12, 13)

The targeting vector of anyone of claims 9-13, wherein the targeting vector comprises a second bait peptide.

### Claim 15 (depends on 14)

The targeting vector of claim 14 wherein the second bait peptide is positioned between the proximal or distal polynucleotide, and the NLS.

### Claim 16 (depends on 15)

The targeting vector of claim 15, wherein the second bait polypeptide and the NLS comprise a combined sequence as set forth in SEQ ID NO: 8.

### Claim 17 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16)

The targeting vector of any one of claims 1-16, wherein the targeting vector comprises a cap on the end of each one of the proximal polynucleotide and the distal polynucleotide.

### Claim 18 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17)

A method for creating a recombinant cell, comprising the steps of (a) assembling a targeting vector of anyone of claims 1-17, (b) contacting a cell with said targeting vector, (c) selecting for the cell comprising the targeting vector in the target polynucleotide by applying a selective pressure, and (d) identifying the cell, which is a recombinant cell.

### Claim 19 (depends on 17)

The method of claim 17 wherein the target polynucleotide is HPRT.
